ﺑﺎﺯﮔﺸﺖ ﺑﻪ ﺻﻔﺤﻪ ﻗﺒﻠﯽ
خرید پکیج
تعداد آیتم قابل مشاهده باقیمانده : -76 مورد

Availability of drugs for treatment of human African trypanosomiasis (HAT) in non-endemic countries

Availability of drugs for treatment of human African trypanosomiasis (HAT) in non-endemic countries
  1. WHO emergency stock of drugs in Geneva
  1. Strategic stocks of anti-trypanosomal medicines
  • Hospital, Royal Liverpool & Broadgreen NHS Foundation Trust, Liverpool (United Kingdom)
  • University College London, NHS Foundation Trust, London (United Kingdom)
  • FMH Innere Medizin und Tropen- und Reisemedizin, Swiss Tropical & Public Health Institut, Basel (Switzerland)
  • Centers for Disease Control and Prevention, Atlanta (USA)
  • Division of Infectious Diseases, Institute of Medical Science, Tokyo (Japan)
  • Universitair Ziekenhuis, Antwerpen (Belgium)
  • Erasmus Medical Center, Rotterdam (The Netherlands)
  • Hospital Clinic, Barcelona (Spain)
  • Netcare Milpark Hospital, Johannesburg (South Africa)
  • National Institute of Parasitic Diseases, China CDC, Shanghai (China)
  • Institute of International Health, Charité University Medicine, Berlin (Germany)
Anti-trypanosomal medicines are donated by Sanofi and Bayer and distributed under the responsibility of WHO or commercially directly from the pharmaceutical company. The medicines are provided to countries in which the disease is endemic through WHO country offices, upon request, according to the needs and information provided.
Report of the third WHO stakeholders meeting on rhodesiense human African trypanosomiasis, World Health Organization, Copyright © 2020. Available at: https://www.who.int/publications/i/item/9789240012936 (Accessed on August 14, 2024).
Graphic 130333 Version 2.0